These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4966799)

  • 1. [What price miracle drugs?].
    Can Hosp; 1968 Mar; 45(3):9,11. PubMed ID: 4966799
    [No Abstract]   [Full Text] [Related]  

  • 2. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.
    Openshaw MS
    Nurs Econ; 2005; 23(6):307-11, 279. PubMed ID: 16459902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [More freedom for the pharmaceutical industry and information on drugs. Interview by C. Kurz].
    Servier J
    Soins; 1983 Apr; (403):45-8. PubMed ID: 6408742
    [No Abstract]   [Full Text] [Related]  

  • 4. Bill C-190.
    Can Med Assoc J; 1968 Feb; 98(5):262. PubMed ID: 5635719
    [No Abstract]   [Full Text] [Related]  

  • 5. When the price is wrong.
    Kennedy D
    Science; 2003 Aug; 301(5635):895. PubMed ID: 12920267
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationships between the academic community and the pharmaceutical industry: the legislative background and its effect on spending on medical research and development.
    Matthews JH
    Clin Invest Med; 1996 Dec; 19(6):470-8. PubMed ID: 8959357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription to over-the-counter deregulation in Canada: are we ready for it, or do we need to be?
    Lynd LD; Taylor J; Dobson R; Willison DJ
    CMAJ; 2005 Sep; 173(7):775-7. PubMed ID: 16157708
    [No Abstract]   [Full Text] [Related]  

  • 8. Supreme Court decision may have major impact on drug industry.
    Spurgeon D
    CMAJ; 1993 Feb; 148(4):629-31. PubMed ID: 8431828
    [No Abstract]   [Full Text] [Related]  

  • 9. Price regulation and generic competition in the pharmaceutical market.
    Dalen DM; Strøm S; Haabeth T
    Eur J Health Econ; 2006 Sep; 7(3):208-14. PubMed ID: 16841230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "New approach" as Health Canada seeks conditional licences for drugs, new pediatric office.
    Eggertson L
    CMAJ; 2005 Mar; 172(7):864. PubMed ID: 15743911
    [No Abstract]   [Full Text] [Related]  

  • 11. No relaxation on drug safety and efficacy.
    Russell AS; Grace M
    World Health Forum; 1993; 14(1):31-3. PubMed ID: 8439367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amendments to the Canadian Patent Act to address drug access: is help on the way?
    Penner MD; Narayanan P
    Food Drug Law J; 2005; 60(3):459-70. PubMed ID: 16304751
    [No Abstract]   [Full Text] [Related]  

  • 13. Can drugs that cause adverse reactions be saved?
    Lee RE
    CMAJ; 1988 Mar; 138(5):455-7. PubMed ID: 3342365
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug manufacturer on the savings package of Ulla Schmidt. "Grip in the moth box of planned economics"].
    Schmidt K
    MMW Fortschr Med; 2001 Nov; 143(44):52. PubMed ID: 11732398
    [No Abstract]   [Full Text] [Related]  

  • 15. Canada or bust? The battle over drug importation.
    Siegel S
    Health Care Law Mon; 2004 Oct; ():3-7. PubMed ID: 15524220
    [No Abstract]   [Full Text] [Related]  

  • 16. Sublicense or supply agreement? Supreme Court of Canada interpretation benefits generic pharmaceutical industry.
    Burshtein S
    Food Drug Law J; 1999; 54(1):73-91. PubMed ID: 11758562
    [No Abstract]   [Full Text] [Related]  

  • 17. The emerging effects of the Drug Price Competition and Patent Term Restoration Act of 1984.
    Lewis RA
    J Contemp Health Law Policy; 1992; 8():361-78. PubMed ID: 10118987
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceuticals: drug importation--2005. End of Year Issue Brief.
    Varma P; Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708457
    [No Abstract]   [Full Text] [Related]  

  • 19. Rx: Canadian drugs.
    Rawson NS
    N Engl J Med; 2004 Mar; 350(11):1155. PubMed ID: 15017685
    [No Abstract]   [Full Text] [Related]  

  • 20. The Drug Price Competition and Patent Term Restoration Act of 1984: fine-tuning the balance between the interests of pioneer and generic drug manufacturers.
    Soehnge H
    Food Drug Law J; 2003; 58(1):51-80. PubMed ID: 12739584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.